Can 5-methyltetrahydrofolate modify the phospholipid fatty acid pattern in cystic fibrosis pediatric patients?

Journal of Cystic Fibrosis

Volumn 5, Issue 3, 2006, Pages 197-199

  Scambi, Cinzia ^a   Guarini, Patrizia ^a   De Franceschi, Lucia ^a   Bambara, Lisa Maria ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

5 Methyltetrahydrofolate; Cystic fibrosis; Docosahexaenoic acid; Fatty acid; Methylation; Phospholipid

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FATTY ACID; FOLIC ACID; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CASE REPORT; CYSTIC FIBROSIS; DISEASE COURSE; ERYTHROCYTE MEMBRANE; FATTY ACID BLOOD LEVEL; FEMALE; GENE MUTATION; HUMAN; LIPID COMPOSITION; LUNG DISEASE; PRESCHOOL CHILD; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

ADULT; CHYMOTRYPSIN; CYSTIC FIBROSIS; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, OMEGA-6; FEMALE; FOLIC ACID; HUMANS; INFANT, NEWBORN; METHYLATION; MILK, HUMAN; TETRAHYDROFOLATES;

EID: 33745975493     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2006.01.006     Document Type: Article

References (12)

1. Strandvik B., Gronowitz E., Enlund F., Martinsson T., and Wahlstrom J. Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis. J Pediatr 139 (2001) 650-655
2. Bhura-Bandali F.N., Suh M., Man S.F., and Clandinin M.T. The deltaF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells. J Nutr 130 12 (2000) 2870-2875
3. Freedman S.D., Katz M.H., Parker E.M., Laposata M., Urman M.Y., and Alvarez J.G. A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr-/- mice. Proc Natl Acad Sci U S A 96 (1999) 13995-14000
4. Freedman S.D., Blanco P.G., Zaman M.M., Shea J.C., Ollero M., Hopper I.K., et al. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 350 (2004) 560-569
5. Biggemann B., Laryea M.D., Schuster A., Griese M., Reinhardt D., and Bremer H.J. Status of plasma and erythrocyte fatty acids and vitamin A and E in young children with cystic fibrosis. Scand J Gastroenterol Suppl 143 (1988) 135-141
6. Roulet M., Frascarolo P., Rappaz I., and Pilet M. Essential fatty acid deficiency in well nourished young cystic fibrosis patients. Eur J Pediatr 156 12 (1997) 952-956
7. Lloyd-Still J.D., Johnson S.B., and Holman R.T. Essential fatty acid status and fluidity of plasma phospholipids in cystic fibrosis infants. Am J Clin Nutr 54 6 (1991) 1029-1035
8. Pita M.L., and Delgado M.J. Folate administration increases n-3 polyunsaturated fatty acids in rat plasma and tissue lipids. Thromb Haemost 84 (2000) 420-423
9. Tacconi M., and Wurtman R.J. Phosphatidylcholine produced in rat synaptosomes by n-methylation is enriched in polyunsaturated fatty acids. Proc Natl Acad Sci U S A 82 14 (1985) 4828-4831
10. Innis S.M., Davidson A.G., Chen A., Dyer R., Melnyk S., and James S.J. Increased plasma homocysteine and S-adenosylhomocysteine and decreased methionine is associated with altered phosphatidylcholine and phosphatidylethanolamine in cystic fibrosis. J Pediatr 143 (2003) 351-356
11. Eidelman O., BarNoy S., Razin M., Zhang J., McPhie P., Lee G., et al. Role for phospholipid interactions in the trafficking defect of Delta F508-CFTR. Biochemistry 41 37 (2002) 11161-11170
12. Zhang L.N., Karp P., Gerard C.J., Pastor E., Laux D., Munson K., et al. Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway. Mol Ther 10 6 (2004) 990-1002